Last updated on: 9/4/2007 | Author:

Avram Goldstein, MD Biography

Former Professor Emeritus of Pharmacology at Stanford University
Pro to the question "Should Marijuana Be a Medical Option?"

“We know that there are no extreme toxicity issues. It is a very safe drug, and therefore it would be perfectly safe medically to let the patient determine their own dose by the smoking route.”

Feb. 27, 1997

Involvement and Affiliations:
  • Professor Emeritus of Pharmacology, Stanford University
  • Member, National Academy of Sciences
  • Chairman, Section of Physiology and Pharmacology, National Academy of Sciences
  • Member, Institute of Medicine
  • Consultant, Receptron, Inc.
  • Consultant, Neurobiological Technologies, Inc.
  • Consultant and Founding Scientist, Affymax, N.V.
  • Recipient, Franklin Medal
  • Recipient, Nathan B.Eddy Award
  • Recipient, Sollmann Award
  • Director, Addiction Research Foundation, Stanford University, 1955-1989
  • Served two terms on the National Advisory Council of the National Institute on Drug Abuse
  • Former Honorary Professor, Beijing Medical University
  • Former Honorary Professor, Institute of Materia Medica of the Academia Sinica
  • Former Scientific Advisor, Syva Company
  • Former Scientific Advisor, DNAX Research Institute
  • Former Scientific Advisor, Abbott Laboratories
  • None found
  • Established the first methadone program in California, in San Jose
  • Contributed important research findings on the use of methadone, LAAM, and naltrexone in the treatment of heroin addicts
  • Played a key role in the development of rapid and efficient on-site urine tests for illicit drug use
  • Born July 3, 1919 in New York City
  • Died June 1, 2012